United States· US:67457-889_69d27b25-c8a3-434c-891d-7d5c1c495e3d
fosaprepitant
A medicinal product containing fosaprepitant, registered in United States by Mylan Institutional LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- fosaprepitant
- Manufacturer
- Mylan Institutional LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1167457889101 VIAL, SINGLE-DOSE in 1 CARTON (67457-889-10) / 5 mL in 1 VIAL, SINGLE-DOSE
Regulatory notes
Same medicine, other countries
Fosaprepitant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainFOSAPREPITANT ACCORD 150 MG POLVO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- NorwayFosaprepitant accordAccord
- GermanyFosaprepitant AmaroxAmarox Pharma Gmbh
- SwedenFosaprepitant Accord 150 mg Pulver till infusionsvätska, lösningAccord Healthcare B.V.
- United KingdomFosaprepitant 150mg powder for solution for infusion vialsAmarox Ltd
- NetherlandsFosaprepitant Amarox 150 mg, poeder voor oplossing voor infusieAmarox Pharma B.V.
- Japanホスアプレピタントメグルミン日本化薬
- SwitzerlandIvemend
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Fosaprepitant Accord, Fosaprepitant Hikma
- Germany · Fosaprepitant Amarox, Fosaprepitant Hikma
- Spain · Fosaprepitant Accord, Fosaprepitant Hikma
- Finland · Fosaprepitant Accord
- United Kingdom (Northern Ireland) · Fosaprepitant Accord Healthcare, Fosaprepitant Amarox
- Iceland · Ivemend
- Italy · Fosaprepitant Accord, Fosaprepitant Hikma
- Liechtenstein · Ivemend
- Netherlands · Fosaprepitant Amarox
- Norway · Fosaprepitant Accord, Ivemend
- Portugal · Fosaprepitant Accord, Fosaprepitant Farmoz
- Sweden · Fosaprepitant Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3122800e-860c-42ef-8381-33faf1cf1c2a GET /v1/drugs/3122800e-860c-42ef-8381-33faf1cf1c2a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "D35FM8T64X",
"rxcui": "754763",
"inchikey": "VRQHBYGYXDWZDL-OOZCZQCLSA-N",
"display_name": "FOSAPREPITANT DIMEGLUMINE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"679c195a-cf59-4ca5-aa05-fa35d08ddb5c": {
"match": "brand_token",
"title": "FOSAPREPITANT INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BRYANT RANCH PREPACK]",
"spl_version": "100",
"published_date": "2026-05-11"
}
},
"productid": "67457-889_69d27b25-c8a3-434c-891d-7d5c1c495e3d",
"productndc": "67457-889",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"orange_book": {
"appl_no": "204015",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 115MG BASE/VIAL",
"product_no": "001",
"approval_date": "Sep 5, 2019"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "EQ 150MG BASE/VIAL",
"product_no": "002",
"approval_date": "Sep 5, 2019"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "FOSAPREPITANT DIMEGLUMINE",
"shortage_reason": "Fosaprepitant Dimeglumine Injection",
"shortage_status": "current",
"proprietary_name": "fosaprepitant",
"active_ingred_unit": "mg/5mL",
"application_number": "ANDA204015",
"marketing_category": "ANDA",
"nonproprietary_name": "fosaprepitant",
"start_marketing_date": "20190905",
"active_numerator_strength": "150"
}See everything about fosaprepitant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.